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The plant immune system involves cell-surface receptors that detect intercellular pathogen-10 
derived molecules, and intracellular receptors that activate immunity upon detection of 11 
pathogen-secreted effectors that act inside the plant cell. Surface receptor-mediated 12 
immunity has been extensively studied1, but intracellular receptor-mediated immunity has 13 
rarely been investigated in the absence of surface receptor-mediated immunity. 14 
Furthermore, interactions between these two immune pathways are poorly understood. By 15 
activating intracellular receptors in the absence of surface receptor-mediated immunity, we 16 
dissected interactions between the two distinct immune systems. Recognition by surface 17 
receptors activates multiple protein kinases and NADPH oxidases; we find intracellular 18 
receptors primarily potentiate the activation of these proteins by elevating their abundance 19 
via multiple mechanisms. Reciprocally, the intracellular receptor-dependent hypersensitive 20 
response is strongly enhanced by activation of surface receptors. Activation of either immune 21 
system alone is insufficient to provide effective resistance against the bacterial pathogen 22 
Pseudomonas syringae. Thus, immune pathways activated by cell-surface and intracellular 23 
receptors mutually potentiate to activate strong defense that thwarts pathogens. These 24 
 
2 
findings reshape our understanding of plant immunity and have broad implications for crop 25 
improvement. 26 
Main Text 27 
Plant cell-surface pattern-recognition receptors (PRRs) recognize pathogen-associated molecular 28 
patterns (PAMPs) and signal via plasma-membrane-associated co-receptor kinases, and 29 
intracellular protein kinases1. Ligand-dependent association between PRRs and these protein 30 
kinases activates calcium influx, production of reactive oxygen species (ROS) via activation of 31 
NADPH oxidases encoded by respiratory burst oxidase homolog (Rboh) genes, activation of 32 
mitogen-activated protein kinases (MAPKs) and induction of defense genes1. 33 
Intracellular nucleotide-binding, leucine-rich-repeat-containing (NLR) receptors activate immune 34 
responses upon recognition of pathogen effectors. Plant sensor NLRs carry either an N-terminal 35 
coiled-coil (CC) domain, or an N-terminal Toll/Interleukin-1 receptor/Resistance protein (TIR) 36 
domain2,3. Upon activation, the CC-NLR ZAR1 forms pentameric resistosome complexes, 37 
associates with plasma membranes (PMs) and likely perturbs their integrity4. The TIR-NLRs Roq1 38 
and RPP1 form tetrameric resistosomes with effectors XopQ and ATR1, respectively5,6. Upon 39 
activation, plant TIR-NLRs require NADase activity of their TIR domains to activate defense7. 40 
TIR-NLR signaling involves the lipase-like proteins EDS1, SAG101 and PAD48. PRRs activate 41 
pattern-triggered immunity (PTI), and NLRs effector-triggered immunity (ETI)9. How PTI and 42 
ETI interact to arrest pathogens is poorly understood. 43 
ETI enhances PTI defense responses 44 
To study ETI without PTI, we generated an Arabidopsis thaliana (Arabidopsis) line with estradiol-45 
inducible expression of bacterial effector AvrRps4 recognized by an intracellular TIR-NLR pair, 46 
RRS1 and RPS4 (RRS1/RPS4). Estradiol induces AvrRps4 expression and activates ETIAvrRps4. 47 
Pre-activation of ETIAvrRps4 elevates plant resistance against Pseudomonas syringae pv. tomato 48 
(Pst) DC300010. To test if ETIAvrRps4 potentiates PTI, we measured ROS production triggered by 49 
flagellin-derived peptide flg22 (a bacterial PAMP) after pre-activating ETIAvrRps4.  ETIAvrRps4 pre-50 
activation elevates ROS production induced by flg22, but induction of ETIAvrRps4 alone does not 51 
activate ROS production (Extended Fig 1a-b). Estradiol pre-treatment in an eds1-2 mutant 52 
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background does not elevate flg22-induced ROS (Extended Fig 1c-d). Thus, ETIAvrRps4 enhances, 53 
but does not initiate, PTI. 54 
During bacterial infection, PTI activation precedes effector delivery. To mimic this, we treated 55 
plants with flg22, or estradiol, or “flg22 + estradiol”, to activate PTI, or ETIAvrRps4 or “PTI + 56 
ETIAvrRps4”. Over 16 hours (h), “PTI + ETIAvrRps4” shows elevated ROS compared to PTI alone, 57 
particularly during Phase III of the burst (Fig 1a, b and Extended Fig 1e, f). ETIAvrRps4 enhances 58 
ROS production triggered by other PAMPs (elf18, C10:0, nlp20 and chitin) and the DAMP pep1 59 
(Extended Fig 2). We investigated if ETI mediated by CC-NLRs also potentiates PTI. The CC-60 
NLR RPS2 recognizes bacterial effector AvrRpt29. We found ETIAvrRpt2 also elevates flg22-61 
induced ROS (Extended Fig 1h-j). Thus, ETI activated by both TIR- or CC-NLRs can enhance 62 
ROS induced by PAMPs. 63 
As “PTI + ETI” enhances the ROS burst of PTI alone, we assessed hydrogen peroxide (H2O2) 64 
levels in leaves after activation of PTI, ETIAvrRps4 and “PTI + ETIAvrRps4”. The non-virulent Pst 65 
DC3000 hrcC mutant (hrcC-) induces PTI. Using diaminobenzidine (DAB) staining, “PTI + 66 
ETIAvrRps4”, but not PTI or ETIAvrRps4 alone, trigger strong H2O2 accumulation after 2 days (Fig 1c). 67 
H2O2 promotes peroxidase-mediated cross-linking of proteins and phenolics in callose cell wall 68 
appositions during PTI11. ETIAvrRps4 alone induces some callose deposition (Fig 1d). Callose 69 
deposition upon co-activation of PTI and ETIAvrRps4 (“PTI + ETIAvrRps4”) is significantly higher 70 
than the sum of that induced by PTI and ETIAvrRps4 alone (Fig 1d-e). Thus, PTI and ETI together 71 
enhance callose deposition. Furthermore, the expression of PTI-responsive genes such as FRK1, 72 
NHL10, FOX1 is significantly higher 24 h after “PTI + ETIAvrRps4” treatment compared to PTI or 73 
ETIAvrRps4 alone (Fig 1f and Extended Fig 1g). In summary, PTI-induced physiological changes 74 
are potentiated and enhanced by ETI. 75 
Upon PAMP recognition, phosphorylation of the receptor-like cytoplasmic kinase subfamily VII 76 
(RLCK-VII) member BIK1 activates the NADPH oxidase RbohD via phosphorylation at its 39th 77 
and 343rd serine residues (S39 and S343). Activated RbohD produces extracellular ROS12,13. PTI 78 
also activates MAPKs, such as MPK3 and MPK6, contributing to transcriptional reprogramming 79 
(Extended Fig 3a)14. We compared the activation of BIK1, RbohD and MAPKs during PTI and 80 
“PTI + ETIAvrRps4”. Both pre-activation and co-activation of ETIAvrRps4 result in prolonged flg22-81 
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induced phosphorylation of BIK1, RbohD (at S39 and S343) and MPK3 (Figure 2a, b, Extended 82 
Fig 3b-e). However, ETIAvrRps4 activation alone does not lead to phosphorylation of RbohD and 83 
MAPKs (Figure 2c, d)10. To investigate how ETI potentiates PTI, we monitored accumulation of 84 
BIK1, RbohD and MPK3 proteins during “PTI + ETIAvrRps4” compared to PTI alone (Figure 2a, b 85 
and Extended Fig 3d, e). More of these proteins accumulate during “PTI + ETIAvrRps4” than during 86 
PTI alone. We assessed protein levels of multiple PTI signaling components during ETI activated 87 
in four additional inducible effector-expressing lines: AvrRpp4, AvrRpt2, AvrRpm1 and AvrPphB, 88 
which are recognized by TIR-NLR RPP4 and CC-NLRs RPS2, RPM1 and RPS5, respectively 89 
(Extended Fig 3f)15. ETI triggered by these effectors elevates protein accumulation of BAK1, 90 
SOBIR1, BIK1, RbohD and MPK3 but not CERK1, FLS2, MPK4 and MPK6 (Extended Fig 3g). 91 
Transcription and translation are strongly correlated during ETI16. We tested if PTI signaling 92 
components are elevated by transcriptional induction. ETI triggered by different effectors strongly 93 
elevates transcript abundance of BAK1, SOBIR1, BIK1, RbohD and MPK3, and weakly that of 94 
CERK1, FLS2, RbohF, MPK4 and MPK6 (Extended Fig 4a, b). Both protein and transcript 95 
accumulation of BIK1, RbohD and MPK3 during ETIAvrRps4 is EDS1-dependent (Extended Fig 4c, 96 
d). Thus, ETI alone boosts transcription of many genes involved in PTI signaling. We performed 97 
genome-wide expression profiling 4 h after induction of ETIAvrRps4 and found ~10% of the 98 
transcriptome shows significant differential gene expression (Extended Fig 5a, b). Most 99 
upregulated genes are enriched in immunity-related biological processes, especially PRR signaling 100 
pathways (Fig 2c, Extended Fig 5c-e). Additional PTI signaling components such as EFR, 101 
PEPR1/2, LORE, LYK5, XLG2, CNGC19 and MKK4/5 are highly upregulated during ETIAvrRps4. 102 
Thus, ETI-dependent gene induction elevates the abundance of PTI signaling components. 103 
Previous studies suggest substantial overlap between PTI- and “PTI + ETI”-induced 104 
transcriptional reprogramming17,18. We tested if increases in PTI signaling components during ETI 105 
are solely due to transcriptional activation. Transcript and protein levels of several PTI signaling 106 
components were monitored over a 24-h time-course post ETIAvrRps4-induction (Fig 3a, b). 107 
Consistent with the protein level, SOBIR1 and BAK1 transcripts are highly induced by ETIAvrRps4 108 
(Fig 3a, b). However, BIK1, RbohD and MPK3 mRNAs are upregulated briefly and then 109 
downregulated after 3 h, while increases in their protein levels are sustained over 24 h (Fig 3a, b 110 
and Extended Fig 6a-e). CERK1, MPK4 and MPK6 transcripts are weakly induced without 111 
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elevating protein abundance. In addition, ETIAvrRps4 and “PTI + ETIAvrRps4” both lead to stronger 112 
BIK1, RbohD and MPK3 accumulation compared to PTI, but their transcript levels differ only 113 
slightly between different conditions (Extended Fig 6f). These results imply that increases in PTI-114 
signaling components during ETIAvrRps4 involves both transcriptional and post-transcriptional 115 
regulation. 116 
We investigated accumulation of PTI-signaling components during ETIAvrRps4 using the translation 117 
inhibitor cycloheximide (CHX) and/or a proteasome inhibitor MG132. CHX blocks the 118 
accumulation of BIK1, RbohD, MPK3 and BAK1 during ETI, but not MPK6 or Actin (Fig 3c and 119 
Extended Fig 7a, b). MG132 treatment results in higher accumulation of BIK1 and RbohD but has 120 
no effect on MPK3 or BAK1 (Fig 3c and Extended Fig 7a, b). MPK3 accumulation is similar 121 
between the combined treatment of CHX and MG132 (“CHX + MG132”) and CHX alone 122 
(Extended Fig 7b), suggesting that elevated MPK3 protein accumulation is likely due to increased 123 
translation rather than decreased protein degradation. BIK1 and RbohD protein levels increase 124 
with “CHX + MG132” treatment compared to those with CHX (Extended Fig 7b), implying that 125 
protein turnover of BIK1 and RbohD also plays a role19,20. However, this increase was not observed 126 
with FLS2, BAK1 or epitope-tagged RPS4 (Extended Fig 7c). Since translational reprogramming 127 
also contributes to immunity21, we compared abundance of ribosome-bound transcripts of ICS1, 128 
SOBIR1, BAK1, BIK1, RbohD and MPK3, normalized to a housekeeping gene EF1α during mock 129 
and ETIAvrRps4 treatment (Extended Fig 7d-f). ETI-induced increases in mRNA levels for BIK1, 130 
RbohD and MPK3 are matched by elevation in ribosome-loaded mRNA levels (Extended Fig 7g-131 
h). ETI thus elevates protein levels of PTI signaling components via multiple and distinct 132 
mechanisms that will be the subject of future investigations. 133 
ETI functions through PTI 134 
Whether ETI and PTI activate the same or distinct mechanisms is poorly defined, because ETI 135 
responses are rarely investigated in the absence of PTI. We tested whether (i) PTI provides the 136 
main defense mechanism against pathogens and (ii) ETI enhances PTI by replenishing PTI 137 
components, thus restoring effector-attenuated PTI. 138 
We challenged plants with non-virulent Pst DC3000 hrcC- and found protein levels of BIK1 and 139 
RbohD are slightly elevated during PTI, and MAPKs are activated and show elevated 140 
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phosphorylation. After infiltration with a virulent strain Pst DC3000, PTI-induced protein 141 
accumulation of BIK1 and RbohD, and MAPK activation is reduced compared to hrcC-, consistent 142 
with effector-triggered susceptibility (ETS)9. We co-infiltrated plants with DC3000 and estradiol 143 
to co-induce ETIAvrRps4 which restored protein levels of BIK1, RbohD and MPK3 and prolonged 144 
activation of MAPKs (Extended Fig 8a). This indicates that ETI overcomes ETS and restores PTI 145 
signaling capacity. 146 
During natural infections, ETI is rarely activated without PTI. We hypothesized that ETI provides 147 
robust resistance by restoring and elevating the abundance of PTI signaling components, 148 
compensating for their turnover upon activation and attenuation by ETS (Extended Fig 8b). This 149 
model implies NLR-mediated resistance functions through PTI. We tested if PTI is required for 150 
NLR-dependent ETI-enhanced disease resistance by infiltrating the PTI-compromised mutants 151 
bak1-5 bkk1-1 and fls2 efr with Pst DC3000 delivering AvrRps4 (DC3000:AvrRps4)22. 152 
Remarkably, bak1-5 bkk1-1 is as susceptible as the NLR mutant rps4-2 rps4b-2 that cannot detect 153 
AvrRps4 (Figure 4a and Extended Fig 8c), while fls2 efr also showed enhanced susceptibility to 154 
DC3000:AvrRps4 compared to wild type (Extended Fig 8d-g). These data show that PTI is 155 
required for RRS1/RPS4-dependent resistance to bacteria, and that activation of ETI in the absence 156 
of PTI is not sufficient for enhanced resistance against P. syringae in Arabidopsis. In addition, 157 
Yuan et al (co-submitted manuscript, 2020-04-06411) provide complementary data, independently 158 
showing that PTI is required for induced bacterial resistance mediated by multiple NLRs. 159 
PTI potentiates ETI-induced cell death 160 
ETI in the presence of PTI often culminates in hypersensitive cell death responses (HR). 161 
Arabidopsis infiltration with a non-pathogenic P. fluorescens Pf0-1 delivering AvrRps4 (Pf0-162 
1:AvrRps4WT) triggers “PTI + ETIAvrRps4” and HR. However, ETIAvrRps4 alone does not lead to HR 163 
(Extended Fig 9a)10. We used a Pf0-1 strain delivering a mutant allele of AvrRps4 (Pf0-164 
1:AvrRps4mut) to activate PTI. Co-activation of PTI and ETIAvrRps4 results in HR and elevated 165 
electrolyte leakage (a widely used indicator of cell death), unlike PTI or ETIAvrRps4 alone (Extended 166 
Fig 9a, b). To test if other PTI-inducers also potentiate HR, we repeated the experiment with either 167 
hrcC- strain Pf0-1, a mixture of PAMPs and a DAMP (flg22, elf18 and pep1), or PAMPs or a 168 
DAMP alone (flg22, elf18, pep1, C10:0, nlp20 or chitin) to activate PTI1. In all cases, only PAMP 169 
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infiltration combined with ETIAvrRps4 triggers HR (Figure 4b and Extended Fig 9c). Thus, PTI 170 
potentiates ETI-induced HR. 171 
Like “PTI + ETIAvrRps4”, co-activation of PTI and ETIAvrRpp4 causes HR, but not PTI or ETIAvrRpp4 172 
alone (Extended Fig 9e). In contrast, inducible expression of AvrRpt2, AvrRpm1 and AvrPphB 173 
that are recognized by CC-NLRs can trigger HR in the absence of PTI (Extended Fig 9d). By 174 
reducing levels of estradiol or dexamethasone, we defined sub-lethal levels of AvrRpt2, AvrRpm1 175 
and AvrPphB induction. At these levels, CC-NLR mediated HR was also enhanced by PTI co-176 
activation (Extended Fig 9e). Thus, PTI activation enhances HR triggered by multiple NLRs. 177 
MAPKs and Rboh proteins promote ETI-dependent HR23,24. To understand PTI-enhanced ETI-178 
associated HR, we investigated the role of MAPKs and Rbohs during ETI alone. We found 179 
MAPKs are phosphorylated during ETIAvrRpm1, ETIAvrRpt2 and ETIAvrPphB, but not during ETIAvrRps4 180 
or ETIAvrRpp4 (Fig 2c and Extended Fig 10a). However, none of the inducible ETIs led to RbohD 181 
phosphorylation at S39 (Extended Fig 10b). ETIAvrRpt2 leads to RbohD phosphorylation at S343 182 
and S34725, which might explain why ETIAvrRpt2 activates a weak ROS burst (Extended Fig 1h-j). 183 
Since ETI potentiates PTI-induced activation of MPK3 and RbohD, and ETI alone leads to weak 184 
or no activation of these components, we tested if HR enhancement by PTI involves the ETI-185 
potentiated activity of MAPKs and NADPH oxidases. In an Arabidopsis line MPK6SR, an mpk3 186 
mpk6 double mutant is complemented by a mutant MPK6 allele (MPK6YG)26. Activity of MPK6YG 187 
but not the wild-type MPK6 can be inhibited by an ATP analogue 1-NA-PP126. We tested the 188 
response to Pf0-1:AvrRps4WT (“PTI + ETIAvrRps4”) in the MPK6SR line in the presence or absence 189 
of 1-NA-PP1. Like others23, we found inhibition of MPK6YG in MPK6SR prevents ETIAvrRps4-190 
associated HR even in the presence of PTI (Extended Fig 10c). Furthermore, HR induced by Pf0-191 
1:AvrRps4WT is reduced in the NADPH oxidase mutant rbohd rbohf (Extended Fig 10d). Together, 192 
these results demonstrate that the activation of MAPK and NADPH oxidases during “PTI + 193 
ETIAvrRps4” contributes to HR.  194 
Discussion 195 
We show here that ETI requires PTI to provide effective resistance. PTI can halt pathogens through 196 
nutrient restriction, cell wall fortification, suppression of bacterial type III secretion and induction 197 
of antimicrobial compounds11,27,28. ETI enhances PTI-induced defense responses via upregulation 198 
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of PTI signaling components, and transcriptional, translational and/or protein turnover control 199 
(Extended Fig 10e). How this is achieved for each PTI component remains to be determined. We 200 
also show that the stronger immune response during “PTI + ETI” involves mutual potentiation of 201 
these two systems.   202 
Our data, and those of Yuan et al (co-submitted manuscript, 2020-04-06411), support a model in 203 
which defenses activated by PRR-dependent signaling are the primary source of immunity, and 204 
activated NLR receptors act to replenish PRR signaling components and enhance PRR-dependent 205 
signaling, counteracting attenuation by turnover upon activation and by pathogen effectors (Fig 206 
4c). In turn, PRR-mediated immunity can potentiate ETI outputs such as HR to further restrict 207 
pathogen proliferation. These data are highly relevant to elevating crop disease resistance. Many 208 
NLR genes are semi-dominant, suggesting ETI strength is rate-limiting for resistance29. Thus, when 209 
PTI is present, stacks of multiple NLR genes should provide physiologically stronger resistance, 210 
as well as enhancing genetic durability, and are a potential source of non-host resistance30. Other 211 
reports have indicated synergistic functions of cell-surface and intracellular receptors in 212 
mammalian immunity31,32, highlighting the relevance of these insights to multiple host-pathogen 213 
systems. 214 
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Fig. 1 | ETI potentiates PTI responses. (a) “PTI + ETIAvrRps4” leads to prolonged ROS production 288 
from 300-960 mins (Phase III). Solid line represents mean ± standard error of the mean (S.E.; 289 
shaded curve). n = 40 leaf disks. (b) Total ROS production in “PTI + ETIAvrRps4”-treated leaves is 290 
significantly higher than PTI-treated leaves. n = 120 leaf disks from three independent 291 
experiments. (c) “PTI + ETIAvrRps4” leads to higher H2O2 accumulation than PTI or ETI
AvrRps4 292 
alone. Scale bars represent 0.5 cm. n = 12 leaves. (d) “PTI + ETIAvrRps4” leads to stronger callose 293 
deposition than PTI or ETIAvrRps4 alone. Numbers represent the mean ±S.E. (e) Callose deposition 294 
in “PTI + ETIAvrRps4”-treated leaves is higher than PTI- or ETIAvrRps4-treated leaves. Mock: n = 21 295 
leaves; PTI, ETI, “PTI + ETI”: n = 23 leaves. (b, e) Centre lines represent medians; bounds of box 296 
indicate the 25th and 75th percentiles; whiskers represent 1.5× interquartile range from 25th and 75th 297 
percentiles. Data points from 3 biological replicates were analyzed with one-sided Kruskal-Wallis 298 
test with Holm correction, then followed by post hoc Dunn’s test. Data points with different letters 299 
indicate significant differences of P < 0.05. P-values were adjusted with Holm correction, and 300 
exact P-values can be found in Supplementary Table 5. (f) “PTI + ETIAvrRps4” leads to a stronger 301 
FRK1, NHL10, FOX1 transcript accumulation compared to PTI or ETIAvrRps4 alone. Data points 302 
from 3 independent experiments were plotted onto the graphs, with ±S.E. for error bars. Two-sided 303 
Welch’s t-test was used to analyze significant differences between “PTI + ETIAvrRps4” and PTI or 304 
ETIAvrRps4. (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; ****, P ≤ 0.001; otherwise, not significant). 305 
Exact P-values can be found in Supplementary Table 5. All experiments were repeated at least 306 
three times with similar results. 307 
Fig. 2 | ETI potentiates activation of PTI signaling components. (a) “PTI + ETIAvrRps4” co-308 
activation leads to increased MPK3 accumulation and prolonged phosphorylation compared to 309 
PTI. (b) “PTI + ETIAvrRps4” co-activation leads to increased BIK1 and RbohD accumulation and 310 
prolonged phosphorylation compared to PTI. (c) ETIAvrRps4 activation alone does not trigger 311 
RbohD-S39 phosphorylation. (d) ETIAvrRps4 alone does not lead to MAPK activation. For (b, c), 312 
microsomal fractions from the samples were isolated for immunoblotting. Molecular weight 313 
marker (in kDa) is indicated on the left. Ponceau staining (PS) was used as loading control. (e) 314 
RNA-seq results of the upregulation of PTI signaling pathway during ETIAvrRps4. Heatmap 315 
representing the expression level of PTI signaling pathway genes, salicylic acid (SA) and pipecolic 316 
acid (PIP) biosynthesis pathway genes and photosynthetic pathway genes at 4 h after ETIAvrRps4 317 
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induction. Red represents upregulation and blue represents downregulation. All experiments were 318 
repeated at least three times with similar results. 319 
Fig. 3 | Accumulation of PTI signaling components during ETI. (a) Relative mRNA expression 320 
changes of SOBIR1, BAK1 (top panel), BIK1, RbohD, MPK3 (middle panel), and CERK1, MPK4, 321 
MPK6 (bottom panel) upon ETIAvrRps4 induction. Samples were taken at indicated time points after 322 
ETIAvrRps4 activation. All samples were normalized against expression of the corresponding genes 323 
in untreated samples (log2FC = 0, dotted line). Solid line represents mean ± S.E. (shaded band).  324 
(b) Protein accumulation of Actin, SOBIR1, BAK1, BAK1, RbohD, MPK3, CERK1, MPK4 and 325 
MPK6 at different time points; Actin is the loading control. Molecular weight is indicated on the 326 
left. Ponceau staining (PS) was used as additional loading control and shown in Extended Fig 6d. 327 
(c) Translation is necessary for the increased protein accumulation of MPK3, RbohD, BIK1, but 328 
not MPK6 and Actin. 7-day-old seedlings were pre-activated with ETIAvrRps4 for 3 h and 329 
subsequently treated with cycloheximide (50 μM; CHX), MG132 (10 μM), or both for indicated 330 
times (2, 4, 8 h). Actin is loading control. Molecular weight (in kDa) is indicated on the left. 331 
Ponceau staining (PS) images of corresponding blots are also shown. All experiments were 332 
repeated at least three times with similar results. 333 
Fig. 4 | PTI and ETI function synergistically to provide robust immunity. (a) Both PTI and 334 
ETIAvrRps4 are required to provide effective immunity against P. syringae. Col-0, rps4-2 rps4b-2 335 
and bak1-5 bkk1-1 were infected with P. syringae pv. tomato (Pst) strain DC3000 carrying empty 336 
vector (grey) or AvrRps4 (pink). Both rps4-2 rps4b-2 (no ETI) and bak1-5 bkk1-1 (PTI-reduced) 337 
are insufficient to provide resistance against Pst DC3000 carrying AvrRps4 compared to Col-0 338 
(“PTI + ETI”). n = 18 leaves. Centre lines represent medians; bounds of box indicate the 25th and 339 
75th percentiles; whiskers represent 1.5× interquartile range from 25th and 75th percentiles. Data 340 
points from 3 biological replicates were analyzed with one-way ANOVA, then followed by post 341 
hoc Tukey’s HSD test. Data points with different letters indicate significant differences of P < 342 
0.05. P-values were adjusted with Holm correction, and exact P-values can be found in 343 
Supplementary Table 5. (b) ETIAvrRps4 leads to macroscopic HR only in the presence of PTI, 344 
activated by either non-virulent Pst DC3000 hrcC-, P. fluorescens Pf0-1 or mixture of flg22, elf18 345 
and pep1 (PAMPs). n = 18 leaves. (c) Schematic representation of the plant immune system. 346 
PAMPs from pathogens are recognized by plant PRRs and induce PTI (red). Virulent pathogens 347 
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secrete effectors to suppress PTI (green). Effectors are recognized by NLRs and induce ETI (dark 348 
yellow arrow), which potentiates PTI to produce robust immune response (blue arrow). All 349 
experiments were repeated at least three times with similar results. 350 
Methods 351 
Plant material and growth conditions 352 
Arabidopsis thaliana Columbia-0 (Col-0) was used as wild type in this study. Seeds were sown on 353 
compost and plants were grown at 21 °C with 10 h under light and 14 h in dark, and at 70% 354 
humidity. The light level is approximately 180-200 µmol with fluorescent tubes. Information about 355 
all plant materials can be found in the referred literatures26,33–37, and were kindly provided by 356 
Jeffery Dangl (Department of Biology, The University of North Carolina at Chapel Hill), Roger 357 
Innes (Department of Biology, Indiana University), Shuta Asai (RIKEN, Japan), Shuqun Zhang 358 
(Division of Biochemistry, University of Missouri), Xiufang Xin (Shanghai Institutes for Biology 359 
Sciences, Chinese Academy of Sciences) and Cyril Zipfel (The Sainsbury Laboratory, UK). 360 
ROS burst assay (pre-treatment with ETI) 361 
Leaf discs harvested with a 6-mm-diameter cork borer from 5-week-old plants were placed in 96-362 
well plates with 200 µl of deionized water overnight in dark (with abaxial surface of the leaves 363 
face down). Leaf discs were then soaked in mock solution (1% DMSO) or 50 μM est (estradiol to 364 
trigger ETIAvrRps4) for 6 h. 200 µl of 20 mm luminol (Sigma-Aldrich, A8511), 0.02 mg/ml 365 
horseradish peroxidase (Sigma-Aldrich, P6782) and 100 nM flg22 were added in each well. ROS 366 
production was measured with a Photek camera (East Sussex, UK). Data from each treatment is 367 
represented by 40 leaf discs in one biological replicate. Every plate was measured over 55 mins.  368 
ROS burst assay (co-treatment with ETI) 369 
Leaf discs harvested with a 6-mm-diameter cork borer from 5-week-old plants were placed in 96-370 
well plates with 200 µl of deionized water overnight in dark (with abaxial surface of the leaves 371 
face down). 200 µl of 20 mm luminol (Sigma-Aldrich, A8511), 0.02 mg/ml horseradish peroxidase 372 
(Sigma-Aldrich, P6782) and indicated elicitors (concentration indicated in Supplementary Table 373 
3) were added in each well. ROS production was measured with a Photek camera (East Sussex, 374 
UK). Data from each treatment is represented by 40 leaf discs in one biological replicate. Every 375 
plate was measured over the 16 h. 376 
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DAB staining 377 
3,3’-diaminobenzidine (Sigma-Aldrich, D8001) was dissolved in water (1 mg/ml) and the pH is 378 
adjusted to 6 with sodium hydroxide. Arabidopsis leaves were infiltrated with indicated solutions 379 
(concentration indicated in Supplementary Table 3). Two days after infiltration, leaves were 380 
vacuum infiltrated with DAB solution for 30 mins and incubated in room temperature for 2 h. The 381 
DAB solution was replaced with 100% ethanol and then boiled for 1 mins. The leaves are then 382 
further de-stained with 70% ethanol under room temperature. De-stained leaves were then scanned 383 
with EPSON Perfection V600 Photo. Scale bar = 0.5 cm. 384 
Callose quantification 385 
Leaves from 5-week-old Arabidopsis were hand-infiltrated with the indicated solutions 386 
(concentration indicated in Supplementary Table 3) and covered for 24 h. Leaves were then hand-387 
infiltrated with 1× PBS buffer containing 0.01% Aniline Blue. Leaf discs were then harvested with 388 
a 6-mm-diameter cork borer for imaging. Images were taken by an epifluorescence microscope 389 
with UV filter (excitation, 365/10 nm; emission, 460/50 nm). The number of callose dots was 390 
calculated by ImageJ software. One leaf disc was harvested per leaf. At least 6 leaves from 391 
individual plants were included per treatment in one biological replicate.  392 
Gene expression analysis by reverse transcription-quantitative polymerase chain reaction (RT-393 
qPCR) 394 
Arabidopsis thaliana tissues were treated with indicated solutions (concentration indicated in 395 
Supplementary Table 3) for indicated time point. Tissues were then snap-frozen and RNA was 396 
isolated by RNeasy Plant Mini Kit (74904; Qiagen) and used for subsequent RT-qPCR analysis. 397 
Reverse transcription was carried out with SuperScript IV Reverse Transcriptase (18090050; 398 
ThermoFisher Scientific). qPCR was performed with KAPA SYBR® FAST (Roche) using the 399 
CFX96 TouchTM Real-Time PCR Detection System. Primers for qPCR analysis are listed in 400 
Supplementary Information Table 2. Data were analyzed using the double delta Ct method38.  401 
Immunoblotting (pre-treatment with ETI) 402 
5-week-old Est:AvrRps4 leaves were sprayed with either mock or 50 μM est solution (in 0.01% 403 
Silwet L-77) and covered for 6 h. Leaves were then infiltrated with 100 nM flg22. Samples were 404 
collected at indicated time points and snap-frozen in liquid nitrogen. Samples were lysed and 405 
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proteins were extracted using GTEN buffer (10% glycerol, 25 mM Tris pH 7.5, 1 mM EDTA, 150 406 
mM NaCl) with 10 mM DTT, 1% NP-40 and protease inhibitor cocktail (cOmplete™, EDTA-free; 407 
Merck), phosphatase inhibitor cocktail 2 (Sigma-Aldrich; P5726) and phosphatase inhibitor 408 
cocktail 3 (Sigma-Aldrich; P0044). After centrifugation at 13,000× rpm for 10 mins to remove cell 409 
debris, protein concentration of each sample was measured using the Bradford assay (Protein 410 
Assay Dye Reagent Concentrate; Bio-Rad). After normalization, extracts were incubated with 2× 411 
TruPAGE™ LDS Sample Buffer (Sigma-Aldrich) at 70 °C for 10 mins. SDS-PAGE gels of 412 
different percentages were used to run protein samples of difference sizes. After transferring 413 
proteins from gels to PVDF membranes (Merck-Millipore) using Trans-Blot Turbo System (Bio-414 
Rad), membranes were blocked with 5% nonfat dried milk in TBST for 1h, immunoblotted with 415 
antibodies specified in Supplementary Information Table 1. Anti-Rabbit IgG (whole molecule)–416 
Peroxidase antibody produced in goat (A0545; Merck-Sigma-Aldrich) was used as secondary 417 
antibody following the use of above antibodies. Ponceau S solution (P7170; Sigma-Aldrich) was 418 
used to stain the PVDF membrane for loading control. For RbohD and BIK1, plasma membrane 419 
protein was extracted for immunoblotting (see below). 420 
Immunoblotting (co-treatment with ETI) 421 
5-week-old est:AvrRps4 leaves were infiltrated with indicated solutions (concentration indicated 422 
in Supplementary Table 3) for indicated time point. Tissues were then collected and snap-frozen. 423 
Proteins were extracted and immunoblotting was performed as stated above. Concentrations of 424 
primary antibodies are specified in Supplementary Information Table 1. Anti-Rabbit IgG (whole 425 
molecule)–Peroxidase antibody produced in goat (A0545; Merck-Sigma-Aldrich) was used as 426 
secondary antibody following the use of above antibodies. Ponceau S solution (P7170; Sigma-427 
Aldrich) was used to stain the PVDF membrane for loading control. For RbohD and BIK1, plasma 428 
membrane protein was extracted for immunoblotting (see below). 429 
Plasma membrane protein extraction 430 
Minute™ Plant Plasma Membrane Protein Isolation Kit (Invent Biotechnologies, SM-005-P) was 431 
used to extract total membrane fraction from Arabidopsis samples as instructed. Protein 432 
concentration of the cytosolic fraction from each sample was measured using the Bradford assay 433 
(Protein Assay Dye Reagent Concentrate; Bio-Rad). After normalization, total membrane fractions 434 
were dissolved in 2× TruPAGE™ LDS Sample Buffer (Sigma-Aldrich) at 70 °C for 5 mins (in a 435 
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minimal volume of 80 μl). 6% SDS-PAGE gels were used to run the protein samples. After 436 
transferring proteins from gels to PVDF membranes (Merck-Millipore) using Trans-Blot Turbo 437 
System (Bio-Rad), membranes were blocked with 5% nonfat dried milk in TBST for 1 h, 438 
immunoblotted with either BIK1, pS39-RbohD or pS343-RbohD antibodies kindly provided by 439 
Jian-Min Zhou (Institute of Genetics and Developmental Biology, Chinese Academy of 440 
Sciences)13. Concentrations of primary antibodies are specified in Supplementary Information 441 
Table 1. Anti-Rabbit IgG (whole molecule)–Peroxidase antibody produced in goat (A0545; 442 
Merck-Sigma-Aldrich) was used as secondary antibody. Ponceau S solution (P7170; Sigma-443 
Aldrich) was used to stain the PVDF membrane for loading control. 444 
Immunoblotting 445 
5-week-old Arabidopsis thaliana leaves were treated with indicated solution (concentration 446 
indicated in Supplementary Table 3). Tissues were then collected and snap-frozen. Proteins were 447 
extracted and immunoblotting was performed as stated above. Concentrations of primary 448 
antibodies are specified in Supplementary Information Table 1. Anti-Rabbit IgG (whole 449 
molecule)–Peroxidase antibody produced in goat (A0545; Merck-Sigma-Aldrich) was used as 450 
secondary antibody following the use of above antibodies. Ponceau S solution (P7170; Sigma-451 
Aldrich) was used to stain the PVDF membrane for loading control.  452 
RNA-seq and data analysis 453 
Leaves from 5-week-old Arabidopsis estradiol-inducible AvrRps4 (est:AvrRps4) or 454 
est:AvrRps4mut 10 were hand-infiltrated with 50 μM estradiol for 0 or 4 h. Samples were collected 455 
and total RNA was isolated with TRI Reagent® (T9424: Sigma-Aldrich) and RNA Clean & 456 
Concentrator-25 Kit (R1018; Zymo Research). RNA samples are processed by BGI and libraries 457 
are sequenced with BGISEQ-500 sequencing platform. At least 10 M single-end 50-bp reads are 458 
obtained for each RNA-seq library. Adaptor-trimmed clean reads have been uploaded to the 459 
European Nucleotide Archive (ENA) (accession ID: PRJEB34955). After FastQC, Kallisto was 460 
used to map and quantify RNA-seq reads39, and kallisto_quant output files are submitted to the 3D 461 
RNA-seq tool for statistics and data visualization40. P-values for differentially expressed (DE) 462 
genes were generated with Fisher Z-transformation after Student's t-test and were adjusted with 463 
Benjamini and Hochberg’s (BH) method40.  464 
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Serial dilution to estimate protein abundance 465 
Fold changes of BIK1, RbohD and MPK3 protein accumulation upon ETIAvrRps4 is estimated by 466 
serial dilution. Protein samples of ETIAvrRps4 at 8 h were diluted 2× (1/2), 4× (1/4), 8× (1/8), 16× 467 
(1/16) and 32× (1/32) in 2× TruPAGE™ LDS Sample Buffer (Sigma-Aldrich). Samples were then 468 
loaded together with protein samples of ETIAvrRps4 at 0 h and ran on 10% SDS-PAGE gels. After 469 
transferring the proteins from gels to PVDF membranes (Merck-Millipore) using Trans-Blot Turbo 470 
System (Bio-Rad), membranes were blocked with 5% nonfat dried milk in TBST for 1 h, 471 
immunoblotted with antibodies specified in Supplementary Information Table 1. Anti-Rabbit IgG 472 
(whole molecule)–Peroxidase antibody produced in goat (A0545; Merck-Sigma-Aldrich) was 473 
used as secondary antibody. Ponceau S solution (P7170; Sigma-Aldrich) was used to stain the 474 
PVDF membrane for loading control.  475 
Cycloheximide and MG132 treatment 476 
1-week-old seedlings of est:AvrRps4 Arabidopsis transgenic line were grown in liquid MS 477 
supplemented with 1% sucrose were pre-treated with 50 μM estradiol or mock (DMSO) for 3 h. 478 
After pre-treatment, cycloheximide (CHX; 50 μM), MG132 (10 μM), or combination of CHX and 479 
MG132 were treated to seedlings in addition to estradiol or mock. Seedlings were harvested 2 h, 480 
4 h, and 8 h after inhibitor treatments. Upon protein extraction, protein concentration was measured 481 
using Bradford assay, and protein samples were analyzed by immunoblotting as described above. 482 
Enrichment of ribosome 483 
Enrichment of ribosome was performed based on previous publications41,42 with modifications. 5-484 
week old Arabidopsis leaves of est:AvrRps4 were infiltrated with mock (1% DMSO) or 50 μM est 485 
for 6 h. 0.6 g of leaves were harvested and ground in liquid nitrogen and extracted with 5 ml 486 
extraction buffer (0.2 M Tris-HCl, pH 8.4, 50 mM KCl, 25 mM MgCl2, 0.5% or Nonidet P-40, 50 487 
μg/ml cycloheximide, RNase inhibitor (RNasin®, Promega). After centrifugation at 13,000× rpm 488 
for 10 mins, supernatant was loaded onto a 1.6 M sucrose cushion. Samples were ultracentrifuged 489 
at 170,000× g for 16 h. Pellet samples were resuspended in 1 ml DEPC-treated water, and 800 μl 490 
was used for RNA extraction and qPCR analysis and 200 μl for protein extraction as described 491 
above. 492 
Bacterial growth assay 493 
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Pseudomonas syringae pv. tomato strain DC3000 carrying AvrRps4 or empty vector pVSP61 was 494 
grown on selective King’s B (KB) medium plates for 48 h at 28 °C. Bacteria were resuspended 495 
and the concentration was adjusted to 0.001 at OD600. Abaxial surfaces of 5-week-old Arabidopsis 496 
leaves were infiltrated with bacterial solution by a 1-ml needleless syringe. For quantification, two 497 
leaf discs per leaf were harvested with a 6-mm diameter cork borer (with disc area of 0.283 cm2). 498 
For “day 0”, samples were ground in infiltration buffer (10 mM MgCl2) and spotted (10 μl/spot) 499 
on selective KB medium. For “day 3”, samples were ground in infiltration buffer, serially diluted 500 
(into 5, 50, 500, 5,000, and 50,000 times), and spotted (6 μl/spot) on selective KB medium. The 501 
number of colonies (CFU per drop) was calculated, and bacterial growth was represented as CFU 502 
cm–2 of leaf tissue. 503 
HR assay in Arabidopsis 504 
Pseudomonas fluorescens Pf0-1 engineered with a type III secretion system (Pf0-1 “EtHAn” 505 
strains) expressing effectors, AvrRps4, AvrRps4KRVY135-138AAAA (mutant AvrRps4; AvrRps4mut)43, 506 
or pVSP61 empty vector were grown on selective KB plates for 24 h at 28 °C. Wild-type 507 
Pseudomonas fluorescens were grown on KB plates with chloramphenicol for 24 h at 28 °C. 508 
Pseudomonas syringae pv. tomato strain DC3000 hrcC- or DC3000 were grown on KB plates with 509 
kanamycin for 48 h at 28 °C. Bacteria were harvested from the plates, resuspended in infiltration 510 
buffer (10 mM MgCl2) and the concentration was adjusted to indicated OD600 (Supplementary 511 
Information Table 3). The abaxial surfaces of 5-week-old Arabidopsis leaves were hand infiltrated 512 
with indicted solution by a 1-ml needleless syringe. Cell death was monitored at indicated time 513 
points after infiltration. 514 
Electrolyte leakage assay 515 
5-week-old Arabidopsis leaves were infiltrated with indicated solutions (Supplementary 516 
Information Table 3) with a 1-ml needleless syringe. Leaf discs were collected with a 2.4-mm-517 
diameter cork borer from infiltrated leaves. Discs were dried and washed in deionized water for 518 
1h before being floated on 10 ml deionized water (15 discs per sample, three samples per biological 519 
replicate). Electrolyte leakage was measured as water conductivity with a Pocket Water Quality 520 
Meters (LAQUAtwin-EC-33; Horiba) at the indicated time points.  521 
Statistical data analysis 522 
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Statistical data were analyzed using the R software (https://www.r-project.org/), and the data were 523 
plotted using the Origin software. For statistical analysis, all data were tested for homoscedasticity 524 
with Levene’s test, and normal distribution with Shapiro-Wilk test, and either parametric one-way 525 
ANOVA analysis followed by Tukey’s post-hoc HSD test, or non-parametric Kruskal-Wallis test 526 
followed by Dunn’s test were applied for statistical significance. Data points with different letters 527 
indicate significant differences of P < 0.01 for Tukey’s HSD test results, and P < 0.05 for Dunn’s 528 
test. Data points are plotted onto the graph, and number of samples for each data are indicated in 529 
corresponding figure legends. Three biological replicates were tested, and individual biological 530 
replicates are indicated with different shapes of the data points. qPCR assay results were analyzed 531 
using two-sided Welch’s t-test for statistical significance (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; 532 
****, P ≤ 0.0001; otherwise, not significant) between samples. Detailed information of sample 533 
number, statistical analysis values for all experiments can be found in the Supplementary Table 5. 534 
Generation of schematic figures  535 
Schematic figures in Fig 2e, 4c, Extended Data Fig 3b, c, 5a, 7d and 10e were created with 536 
BioRender.com. 537 
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Extended Data Fig. 1 | ETIAvrRps4 and ETIAvrRpt2 potentiates PTI responses. (a) Estradiol pre-605 
treatment in est:AvrRps4 leads to stronger and prolonged ROS burst compared to mock pre-606 
treatment. n = 40 leaf disks. (b) ROS accumulation over 55 mins in ETIAvrRps4-pretreated leaves is 607 
significantly higher than mock-pretreated leaves. n = 120 leaves over 3 independent experiments. 608 
(c) Pre-treatment of estradiol in est:AvrRps4 eds1-2 does not lead to stronger and prolonged ROS 609 
burst compared to mock pre-treatment. n = 40 leaf disks. (d) ROS accumulation over 55 mins in 610 
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ETIAvrRps4-pretreated leaves in the eds1-2 is comparable to mock-pretreated leaves. n = 120 leaves 611 
over 3 independent experiments. (e) ROS accumulation of PTI, ETIAvrRps4 and “PTI + ETIAvrRps4” 612 
treated leaves during Phase I (0-60 mins), Phase II (60-300 mins) and Phase III (300-960 mins). n 613 
= 120 leaves over 3 independent experiments.. (f) Summary table of ROS accumulation in different 614 
phases. (g) “PTI + ETIAvrRps4” leads to a stronger PER4, WRKY31 transcript accumulation 615 
compared to PTI or ETIAvrRps4 alone. ICS1 transcript is induced upon “PTI + ETIAvrRps4” as well as 616 
ETIAvrRps4 alone.  Data points from 3 independent experiments were plotted onto the graphs, with 617 
±S.E. for error bars. Two-sided Welch’s t-test was used to analyze significance differences 618 
between PTI + ETIAvrRps4 and PTI or ETIAvrRps4 (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; ****, P 619 
≤ 0.001; otherwise, not significant). Exact P values can be found in Supplementary Table 5. (h) 620 
PTI + ETIAvrRpt2 leads to prolonged ROS production during Phase II. n = 40 leaf disks. (i) ROS 621 
accumulation of PTI, ETIAvrRpt2 and PTI+ETIAvrRpt2 treated leaves during Phase I, Phase II and 622 
Phase III and in total. n = 120 leaves over 3 independent experiments. (j) Summary table of ROS 623 
accumulation in different phases. For (a), (c), (h) Solid line represents mean ± S.E. (shaded curve) 624 
from one biological replicate. For (b), (d), (e), (i), data points from 3 independent experiments 625 
were analyzed with one-sided Kruskalis-Wallis test followed by post hoc Dunn’s test. Different 626 
letters next to the boxplot indicate significant differences of P < 0.05.  Centre lines represent the 627 
medians; bounds of box indicate the 25th and 75th percentiles; whiskers represent 1.5× interquartile 628 
range from 25th and 75th percentiles. P-values were adjusted using Holm correction, and exact P-629 
values can be found in Supplementary Table 5. All experiments were repeated at least three times 630 
with similar results. 631 
Extended Data Fig. 2 | ETIAvrRps4 enhances ROS production triggered by different PAMPs 632 
and DAMP. (a-c) elf18-triggered ROS production in the presence of ETIAvrRps4 is stronger than 633 
elf18 treatment alone. (d-f) pep1-triggered ROS production in the presence of ETIAvrRps4 is stronger 634 
than pep1 treatment alone. (g-i) C10:0-triggered ROS production in the presence of ETIAvrRps4 is 635 
stronger than C10:0 treatment alone. (j-l) nlp20-triggered ROS production in the presence of 636 
ETIAvrRps4 is stronger than nlp20 treatment alone. (m-o) Chitin-triggered ROS production in the 637 
presence of ETIAvrRps4 is stronger than chitin treatment alone. Shaded curves in (a), (d), (g), (j), 638 
(m) represent standard error (S.E.) and solid line represents mean.. n = 40 leaf disks. ROS 639 
production in Phase I, Phase II, Phase III and total are shown as boxplots in (b), (e), (h), (k) and 640 
(n). Centre lines represent the medians; bounds of box indicate the 25th and 75th percentiles; 641 
 
23 
whiskers represent 1.5× interquartile range from 25th and 75th percentiles. Data points from 3 642 
independent experiments were analyzed with one-sided Kruskalis-Wallis test followed by post hoc 643 
Dunn’s test. Different letters next to the boxplot indicate significant differences of P < 0.05. n = 644 
120 leaves over 3 independent experiments. P values were adjusted using Holm correction, and 645 
exact P values can be found in Supplementary Table 5. (c), (f), (i), (l), (o) Tabular summary of 646 
total ROS production in different phases upon different PAMPs or DAMP treatments with 647 
ETIAvrRps4 co-activation. All experiments were repeated at least three times with similar results. 648 
Extended Data Fig. 3 | Protein accumulation of PTI signaling components during ETI. (a) 649 
PTI signaling pathway. (b-c) Schematic representation of “natural infection mimicking” and “ETI 650 
pre-activation” experimental design. ETIAvrRps4 was activated by estradiol treatment. ✶ indicates 651 
activated immune system. (red: PTI activation; yellow: ETI activation, blue: PTI and ETI co-652 
activation). (d) Pre-activation of ETIAvrRps4 leads to accumulation and prolonged phosphorylation 653 
of MPK3 compared to mock pre-treatment. (e) Pre-activation of ETIAvrRps4 leads to accumulation 654 
and prolonged phosphorylation of BIK1 and RbohD (S39 and S343) compared to mock pre-655 
treatment. Microsomal fractions from each sample were isolated for immunoblotting. Molecular 656 
weight marker (in kDa) is indicated on the left. Ponceau staining (PS) was used as loading control. 657 
(f) Transcript induction of corresponding effectors and ICS1 upon induced expression of AvrRpm1 658 
(dex:AvrRpm1), AvrRpt2 (est:AvrRpt2), AvrPphB (est:AvrPphB), AvrRps4 (est:AvrRps4) and 659 
AvrRpp4 (est:AvrRpp4). Extracted RNA were analyzed by qPCR and expression level is presented 660 
as relative to EF1α.  Data points from 3 independent experiments were plotted onto the graphs, 661 
with ±S.E. for error bars.. Two-sided Welch’s t-test was used to analyze significance in differences 662 
of 4 h, 8 h data points from 0h. (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; ****, P ≤ 0.001; 663 
otherwise, not significant). Exact P-values can be found in Supplementary Table 5. (g) Protein 664 
accumulation of BAK1, SOBIR1, BIK1, RbohD, MPK3, MPK6, FLS2, CERK1 and MPK4 upon 665 
ETI activation for 4 h, 8 h in multiple effector inducible lines. 5-week-old leaves of inducible-666 
AvrRpm1, AvrRpt2, AvrPphB, AvrRps4 and AvrRpp4 lines were infiltrated with 50μM dex (for 667 
dex:AvrRpm1) or 50μM est. Samples were collected at 0, 4 and 8 h post infiltration (hpi) for 668 
protein extraction. Molecular weight marker (in kDa) is indicated on the left. Ponceau staining 669 
 
24 
(PS) were used as loading control. All experiments were repeated at least three times with similar 670 
results. 671 
Extended Data Fig. 4 | Transcript accumulation of PTI signaling components during ETI. 672 
(a) Relative gene expression of BAK1, SOBIR1, BIK1, RbohD, MPK3, MPK6, FLS2, CERK1, 673 
MPK4 and RbohF relative to EF1α in multiple effector-inducible lines. 5-week-old leaves of 674 
inducible-AvrRpm1, AvrRpt2, AvrPphB, AvrRps4 and AvrRpp4 lines were infiltrated with 50 μM 675 
dex (for dex:AvrRpm1) or 50 μM est. Samples were collected at 0, 4 and 8 hpi for RNA extraction. 676 
(b) Heatmap of fold-changes (log2FC) of BAK1, SOBIR1, BIK1, RbohD, MPK3, MPK6, FLS2, 677 
CERK1, MPK4 and RbohF from (a). Gene expression at 4 h and 8 h was normalized to expression 678 
level at 0 h. Red indicates upregulation and blue indicates downregulation. (c) Protein 679 
accumulation of BIK1, RbohD, and MPK3 during ETIAvrRps4 is abrogated in eds1-2. Proteins were 680 
extracted from est:AvrRps4 and est:AvrRps4 eds1-2 upon est treatment for 0 h, 4 h, and 8 h. 681 
Molecular weight marker (in kDa) is indicated on the left. Ponceau staining (PS) were used as 682 
loading control. (d) Transcript induction of BIK1, RbohD, and MPK3 during ETIAvrRps4 is 683 
abrogated in eds1-2. For (a) and (d), extracted RNA were analyzed by qPCR and expression level 684 
is presented as relative to EF1α.  Data points from 3 independent experiments were plotted onto 685 
the graphs, with ±S.E. for error bars. Two-sided Welch’s t-test was used to analyze significance in 686 
differences of 4 h, 8 h data points from 0h (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; ****, P ≤ 687 
0.001; otherwise, not significant). Exact P-values can be found in Supplementary Table 5. All 688 
experiments were repeated at least three times with similar results. 689 
Extended Data Fig. 5 | Genome-wide gene expression profiling of ETIAvrRps4. (a) Schematic 690 
design of RNA-seq analysis. 5-week-old inducible lines of wild-type AvrRps4 (est:AvrRps4) and 691 
mutant AvrRps4 (estradiol-inducible AvrRps4KRVY135-138AAAA-expressing line or est:AvrRps4mut) 692 
were infiltrated with mock or 50 μM est and samples were collected at 0 h, and 4 h. Samples from 693 
three biological replicates were collected for RNA-seq analysis. (b) 2573 differentially expressed 694 
(DE) genes were identified as significant in comparison between est:AvrRps4 treated with 695 
estradiol for 0 h (est:AvrRps4, Est-0h) and est:AvrRps4 treated with est for 4 h (est:AvrRps4, Est-696 
4h). P values for differentially expressed (DE) genes were generated with Fisher Z-transformation 697 
after Student's t-test. DE genes with “Benjamini and Hochberg’s (BH) method” false discovery 698 
rate (FDR) two-sided adjusted P-value (adj.pval) < 0.01 are categorized as significant. Heatmap 699 
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representing the 2573 DE genes during 5 treatments; est:AvrRps4 (Untreated), est:AvrRps4 treated 700 
with est for 0 h (Est-0h), est:AvrRps4 treated with est for 4 h (Est-4h), est:AvrRps4mut treated with 701 
est for 0 h (Est-0h) and est:AvrRps4mut treated with est for 4 h (Est-4h). Genes that are specifically 702 
upregulated during ETIAvrRps4 are in cluster 7 and 8. (c-e) GO enrichment analysis of genes from 703 
cluster 7 and 8. (c) Top three significantly enriched biological process GO-terms in cluster 7 and 704 
8. (d) Top four significantly enriched molecular function GO-terms in cluster 7 and 8. (e) Top four 705 
significantly enriched cellular component GO-terms in cluster 7 and 8. For details of GO 706 
enrichment analysis refer to Source Data. (f) Red (positive log2FC (fold change)) represents genes 707 
that are significantly induced and blue (negative log2FC) represents genes that are significantly 708 
repressed. BH-FDR two-sided adjusted P-value (adj.pval) < 0.05 is considered as significant. 709 
Gradient of green color indicates significance of the adjusted P-value. For full list of DE genes 710 
refer to Supplementary Table 4.  711 
Extended Data Fig. 6 | Expression dynamics of PTI signaling components during ETIAvrRps4. 712 
(a) Transcript induction of SOBIR1, BAK1, BIK1, RbohD, MPK3, CERK1, MPK4, MPK6, ICS1, 713 
PR1 during ETIAvrRps4 over 24 h. Transcript levels were normalized to EF1α.  Data points from 3 714 
independent experiments were plotted onto the graphs, with ±S.E. for error bars. Two-sided 715 
Welch’s t-test was used to analyze significance in differences of data points from ETIAvrRps4-716 
activated samples compared to untreated (UNT) samples (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; 717 
****, P ≤ 0.001; otherwise, not significant). Exact P values can be found in Supplementary Table 718 
5. (b) Relative mRNA expression changes of ICS1 (green) and PR1 (black) during ETIAvrRps4. 719 
Relative expression changes of the corresponding genes to untreated samples (Log2FC = 0, dotted 720 
line) are shown. Solid line represents mean ± S.E. (shaded band). (c) Heatmap representing fold-721 
changes (log2FC) of transcripts from (a). Gene expression at indicated time points are relative 722 
value to untreated samples. Red indicates upregulation and blue indicates downregulation. (d) 723 
Protein accumulation of PR1 at different time points. Ponceau staining of western blots from Fig. 724 
3b are also shown. (e) Serial dilution to estimate protein accumulation of BIK1, RbohD and MPK3 725 
at 8h after ETIAvrRps4 activation compared to 0 h. Red asterisk indicates approximate fold 726 
differences between 0 h and 8 h. (f) 5-week old Arabidopsis rosette leaves of est:AvrRps4 were 727 
treated with hrcC-, est, or “hrcC- + est” for indicated timepoints and both RNA and proteins were 728 
extracted. Extracted RNA were analyzed by qPCR and expression level is presented as relative to 729 
EF1α.  Data points from 3 independent experiments were plotted onto the graphs, with ±S.E. for 730 
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error bars (PTI: red; ETIAvrRps4: yellow; “PTI + ETIAvrRps4”: blue). Two-sided Welch’s t-test was 731 
used to analyze significance in differences of 4h, 8h data points from 0h (*, P ≤ 0.05; **, P ≤ 0.01; 732 
***, P ≤ 0.005; ****, P ≤ 0.001; otherwise, not significant). Exact P-values can be found in 733 
Supplementary Table 5. For (d), (e), (f), Ponceau staining (PS) was used as loading control. 734 
Molecular weight marker (in kDa) is indicated on the left. All experiments were repeated at least 735 
three times with similar results. 736 
Extended Data Fig. 7 | Multiple mechanisms are involved in the upregulation of PTI signaling 737 
components during ETIAvrRps4. (a) Relative gene expression of ICS1, BIK1, RbohD, MPK3 and 738 
MPK6 in seedlings pre-activated with ETIAvrRps4 for 3 h prior to treatment with cycloheximide 739 
(CHX) and MG132.  Data points from 3 independent experiments were plotted onto the graphs, 740 
with ±S.E. for error bars.. Two-sided Welch’s t-test was used to analyze significance in differences 741 
at 3h compared to 0h (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; ****, P ≤ 0.001; otherwise, not 742 
significant). Exact P values can be found in Supplementary Table 5. (b, c) Protein accumulation 743 
of MPK3, RbohD, BIK1, MPK6, Actin in seedlings pre-treated with Mock (DMSO) for 3 h (b), 744 
and RPS4-HA, FLS2, and BAK1 (c) in seedlings pre-treated with Mock or est, subsequently 745 
treated with CHX (50 μM), MG132 (10 μM), or both for indicated times (2 h, 4 h, 8 h). Actin was 746 
used as loading control. Ponceau staining (PS) of corresponding blots are shown below. For FLS2 747 
and Actin, as well as BAK1 and BIK1, immunoblot was performed with membranes cut in half 748 
(above 70 kDa for FLS2, BAK1, respectively, below 70 kDa for Actin and BIK1 immunoblot, 749 
respectively). Therefore, Ponceau staining (PS) for FLS2 and Actin, BAK1 and BIK1, respectively, 750 
are identical. (d) Schematic representation of ribosome enrichment. (e-f) Ribosome was enriched, 751 
and (e) total extract (T), supernatant (S), and ribosomal pellet (P) samples were blotted with RPS6 752 
and RPL10 antibody.  For (b), (c) and (e), Ponceau staining (PS) was used as loading control. 753 
Molecular weight marker (in kDa) is indicated on the left. (f) RNA extracted from total extract 754 
(Total RNA), and ribosomal pellet (Ribosome RNA) from mock and est-treated est:AvrRps4 755 
samples were loaded on an agarose gel. 28S and 18S rRNA are indicated. (g) Relative expression 756 
of ICS1, SOBIR1, BAK1, BIK1, RbohD and MPK3 to EF1α from total RNA (Total) and ribosomal 757 
pellet (Ribosomal).  Data points from 3 independent experiments were plotted onto the graphs, 758 
with ±S.E. for error bars. Two-sided Welch’s t-test was used to analyze significance in differences 759 
of 6 h compared to 0 h (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; ****, P ≤ 0.001; otherwise, not 760 
significant). Exact P-values can be found in Supplementary Table 5. (h) Ratio of ribosomal RNA 761 
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to total RNA (relative to EF1α) of ICS1, SOBIR1, BAK1, BIK1, RbohD and MPK3 in mock and 762 
ETI samples. Values are calculated from the transcripts retained in the ribosomal samples over 763 
total samples. Data points from 3 independent experiments were plotted onto the graphs, with 764 
±S.E. for error bars. All experiments were repeated at least three times with similar results. Two-765 
sided Welch’s t-test was used to analyze significance in differences of the translation efficiency 766 
(T.E.) between Mock and ETI-treated samples (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.005; ****, P 767 
≤ 0.001; otherwise, not significant). Exact P-values can be found in Supplementary Table 5. 768 
Extended Data Fig. 8 | ETI functions through PTI. (a) 5-week-old leaves of est:AvrRps4 were 769 
infiltrated with Pst strain DC3000 hrcC- (Pst hrcC-; triggers PTI), Pst DC3000 (Pst; triggers “PTI 770 
+ ETS”), or “50 μM est + Pst hrcC-”(triggers “PTI - ETS + ETIAvrRps4”), and samples were 771 
collected at the indicated time points for protein extraction and immunoblotting. PTI leads to 772 
activation of MAPKs and accumulation of BIK1 and RbohD (red). Pst secretes effectors to block 773 
PTI (green). Co-activation of PTI and ETIAvrRps4 leads to stronger accumulation of MPK3, BIK1 774 
and RbohD compared to PTI (blue). MAPKs activation is also prolonged during “PTI + 775 
ETIAvrRps4”. (b) Updated version of the “zig-zag-zig” model. (c) Col-0, rps4-2 rps4b-2 and bak1-776 
5 bkk1-1 were infected with Pst DC3000 carrying AvrRps4 (red) or empty vector (grey). Bacterial 777 
growth at 0 dpi as measured. n = 12 leaves. (d) Col-0, rps4-2 rps4b-2 and fls2 efr were infected 778 
with Pst DC3000 carrying AvrRps4 (red) or empty vector (grey). Both rps4-2 rps4b-2 (No ETI) 779 
and fls2 efr (PTI-reduced) are insufficient to provide resistance against Pst DC3000:AvrRps4 780 
compared to Col-0 (“PTI + ETI”). Day 0: n = 12 leaves; day 3: n = 18 leaves. For (c), (d), data 781 
points were analyzed by one-way ANOVA followed by post hoc Tukey’s HSD test. Data points 782 
with different letters indicate significant differences of P < 0.01. (e) flg22-induced ROS burst is 783 
not affected in rps4-2 rps4b-2. Shaded curve represents standard error (S.E.) and solid line 784 
represents average value from 24 leaves in each treatment during n = 24 leaves . (f) flg22-induced 785 
ROS production over 55 mins in Col-0 and rps4-2 rps4b-2. Data points from 3 biological replicates 786 
were analyzed with one-sided Kruskal-Wallis test followed by post hoc Dunn’s test. Data points 787 
with different letters indicate significant differences of P < 0.05. n = 72 leaves over 3 independent 788 
experiments. (g) flg22-induced MPK phosphorylation is not affected in rps4-2 rps4b-2. Upon 789 
flg22 treatment, samples were taken at indicated time points for immunoblotting. For (a), (g), 790 
Ponceau staining (PS) was used as loading control. Molecular weight marker (in kDa) is indicated 791 
on the left. All experiments were repeated at least three times with similar results. For (c), (d), (f), 792 
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centre lines represent the medians; bounds of box indicate the 25th and 75th percentiles; whiskers 793 
represent 1.5× interquartile range from 25th and 75th percentiles. Exact P-values can be found in 794 
Supplementary Table 5. 795 
Extended Data Fig. 9 | Potentiation of ETIAvrRps4-induced HR by PTI. (a) Pf0-1:AvrRps4 leads 796 
to macroscopic HR in est:AvrRps4 leaves. Both PTI (Pf0-1:AvrRps4mut) or ETIAvrRps4 (est) does 797 
not lead to macroscopic HR. Coactivation of PTI and ETIAvrRps4 (est + Pf0-1:AvrRps4mut)  leads to 798 
macroscopic HR. The numbers indicate number of leaves displaying HR of the total number of 799 
leaves infiltrated. n = 18 leaves. (b) Est:AvrRps4 leaves were hand-infiltrated with indicated 800 
solutions and electrolyte leakage was measured over 48hpi. Combination of “PTI + ETIAvrRps4” 801 
(blue dots, “est + Pf0-1:AvrRps4mut”) leads to stronger electrolyte leakage compared to ETIAvrRps4 802 
(est) or PTI (Pf0-1:AvrRps4mut) alone. Pf0-1:AvrRps4 (green) acts as a positive control. Data 803 
points from 3 biological replicates were analyzed with one-way ANOVA followed by post hoc 804 
Tukey’s HSD test. Data point from each biological replicate is indicated with different shapes. 805 
Data points with different letters indicate P < 0.01. n = 9 data points; each represents data from 15 806 
leaf discs. Exact P-values can be found in Supplementary Table 5. (c) PTI induced by flg22, elf18, 807 
pep1, C10:0, nlp20 or chitin does not lead to macroscopic HR. Coactivation of PTI (trigger by 808 
these PAMPs or DAMP) with ETIAvrRps4 leads to macroscopic HR. The numbers indicate number 809 
of leaves displaying HR of the total number of leaves infiltrated. n = 18 leaves. (d) 5-week-old 810 
inducible AvrRpm1 (dex:AvrRpm1), AvrRpt2 (est:AvrRpt2), AvrPphB (est:AvrPphB), AvrRps4 811 
(est:AvrRps4) and AvrRpp4 (est:AvrRpp4) Arabidopsis leaves were infiltrated with either dex (for 812 
dex:AvrRpm1 only) or est. All pictures were taken at 3 dpi. The numbers indicate the number of 813 
leaves displaying HR of the total number of leaves infiltrated. n = 18 leaves. (e) Combination of 814 
“PTI + ETI” leads to stronger macroscopic HR in inducible-AvrRpm1, AvrRpt2, AvrPphB and 815 
AvrRpp4 Arabidopsis lines. All pictures were taken 3 dpi. The numbers indicate number of leaves 816 
displaying HR of the total number of leaves infiltrated. n = 18 leaves. All experiments were 817 
repeated at least three times with similar results. 818 
Extended Data Fig. 10 | MAPKs and NADPH oxidases are involved in HR induced by PTI + 819 
ETI. (a) MPK phosphorylation during ETI triggered by multiple effectors. Seedlings of 820 
dex:AvrRpm1, est:AvrRpt2, est:AvrPphB and est:AvrRpp4 lines were soaked in dex or est, 821 
solution respectively for indicated time points (dark yellow). Untreated (UNT) seedlings were used 822 
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as negative control, seedlings treated with 100 nM flg22 for 15 min (red, flg22) were used as 823 
positive control. (b) RbohD phosphorylation during ETI triggered by multiple effectors. Seedlings 824 
of dex:AvrRpm1, est:AvrRpt2, est:AvrPphB and est:AvrRpp4 were soaked in either mock (black), 825 
dex or est solution (dark yellow) for 6 h. Microsomal fraction from seedlings were isolated for 826 
immunoblotting. For (a), (b), Ponceau staining (PS) was used as loading control. Molecular weight 827 
marker (in kDa) is indicated on the left. (c) MPK6SR#58 (mpk3 mpk6 PMPK6:MPK6
YG) is a 828 
conditional mpk3 mpk6 double mutant. MPK6YG has a larger ATP binding pocket than MPK6WT 829 
and is sensitive to the inhibitor 1-Naphthyl-PP1 (NA-PP1, ATP analog). Pre-treatment with NA-830 
PP1 inhibits MPK6YG and temporarily generates a mpk3 mpk6 double mutant. Both Col-0 and 831 
MPK6SR#58 leaves were pre-infiltrated with either 1% DMSO (mock) or 10 μM NA-PP1. After 832 
3 h, these leaves were infiltrated with either Pf0-1:empty vector (triggers PTI) or Pf0-1:AvrRps4 833 
(triggers “PTI + ETIAvrRps4”). With mock pre-treatment, Pf0-1:AvrRps4 infiltration leads to 834 
macroscopic HR in both Col-0 and MPKS6R#58. NA-PP1 pre-treatment attenuates HR caused by 835 
Pf0-1:AvrRps4 only in the MPK6SR#58 line. All pictures were taken at 1 dpi. The numbers 836 
indicate number of leaves displaying HR of the total number of leaves infiltrated. n = 18 leaves. 837 
(d) Col-0 and rbohd rbohf leaves were infiltrated with either Pf0-1:empty vector (triggers PTI) or 838 
Pf0-1:AvrRps4 (triggers “PTI + ETIAvrRps4”) at varying OD600. With OD600 = 0.025, Pf0-839 
1:AvrRps4 infiltration leads to less macroscopic HR in rbohd rbohf. All pictures were taken 1 dpi. 840 
The numbers indicate number of leaves displaying HR of the total number of leaves infiltrated. n 841 
= 18 leaves. All experiments were repeated at least three times with similar results. (e) Model: 842 
Upon ligand detection by PRRs, PTI leads to activation of BIK1, RbohD and MAPKs. Activation 843 
of an NLR (ETI without PTI) elevates accumulation of PTI signaling components. Co-activation 844 
of both PTI and ETI elevates accumulation and enhances activation of multiple PTI signaling 845 
components, enabling a stronger immune response.  846 
